Ishares Msci Brazil ETF vs Nuwellis Inc — how do they compare? Ishares Msci Brazil ETF trades at $34.1, while Nuwellis Inc trades at $1.48 (market cap $542.80K). The key difference: Ishares Msci Brazil ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| EWZ | NUWE | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $41.75 | $220.50 |
52-Week Low | $27.36 | $1.42 |
Market Cap | — | $542.80K |
Enterprise Value | — | -$1.27M |
Signals from Pluang's Aura AI — not financial advice
EWZ trades at $35.34, down 1.31% today, with a bearish technical signal from moving averages. The ETF tracks Brazilian equities, facing headwinds from US tariffs and currency volatility. Recent institutional buying includes Empowered Funds' $3.06 million position (Defense World, Aug 5, 2026), while technical support sits at $34-$35.
Outlook hinges on Brazil's economic policies and commodity prices. Opportunities exist if rate cuts continue, but risks include political uncertainty and competitive pressure from lower-fee alternatives like FLBR. The dividend yield of approximately 3.78% provides income, but consistency is challenged by reliance on commodity-driven holdings.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →